InsidersTradesSigma
Discover the complete record of transactions filed by Hudson Thomas J, Vice-Président Senior, R&D et Directeur Scientifique. Director active across 1 company, notably AbbVie Inc.. In total, 2 disclosures have been published. Activity tracked since 17 February 2022. The latest transaction was disclosed on 25 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Thomas J. Hudson is the SVP, R&D and CSO at AbbVie Inc. He oversees the company's research and development initiatives, contributing to innovation and advancement in medical treatments. Hudson plays a key role in AbbVie's research strategy, aiming to improve patient health.